Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%

Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%

Source: 
Xconomy
snippet: 

An experimental Sage Therapeutics drug intended to alleviate depression symptoms quickly has failed to beat a placebo in a pivotal study, the company reported Thursday.